Baxter International Inc (BAX)

Industry Medical Instruments & Supplies
This stock can be held in an Investment ISA and an Investment Account
Sell

$31.21

Buy

$32.00

arrow-up$0.62 (+2.00%)

Baxter International Inc operates in the healthcare industry. It provides renal and hospital products such as infusion systems and systems, parenteral nutrition therapies, and biosurgery products.
Prices updated at 17 May 2025, 00:59 EDT
| Prices minimum 15 mins delay
|
Prices in USD
S&P 500
arrow-up0.7%
NYSE
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
Our Investment Fees and Charges.

Income statement

Year
chevron-l-regular
chevron-r-regular
20172018201920202021202220232024
10,584m11,099m11,362m11,673m12,146m10,057m10,360m10,636m
4,474m4,759m4,761m4,587m4,720m3,549m4,150m3,984m
1,288m1,584m1,772m1,597m1,344m-33m707m439m
12.1714.2715.6013.6811.07-0.336.824.13
602m1,546m1,001m1,102m1,284m-2,433m2,656m-649m
1,935m2,481m1,870m2,268m2,190m-1,763m1,734m1,116m
Sales, General and administrative2,627m2,620m2,535m2,469m2,845m3,097m2,953m2,967m
Interest expenses85m93m111m153m207m413m508m408m
Provision for income taxes491m65m-41m182m83m-135m61m37m
Operating expenses3,186m3,175m2,989m2,990m3,376m3,582m3,443m3,545m
Income before taxes1,100m1,617m970m1,292m1,116m-3,248m242m-289m
Net income available to common shareholders602m1,546m1,001m1,102m1,284m-2,433m2,656m-649m
1.323.041.972.172.56-4.835.25-1.27
Net interest income-55m-45m-71m-134m-193m-394m-439m-341m
Advertising and promotion--------
Net investment income, net--------
Realised capital gains (losses), net--------
Total benefits, claims and expenses--------
Earnings per share (diluted)1.292.971.932.132.53-4.835.25-1.27
Free cash flow per share2.5812.11262.13172.55832.92761.49161.760.767
Book value/share17.481817.797315.43416.967217.483510.972715.958415.4073
Debt equity ratio0.384590.4437790.6748290.7235591.9467892.6879821.3513451.524555

Balance sheet

Year
chevron-l-regular
chevron-r-regular
20172018201920202021202220232024
Current assets7,263m5,919m7,503m8,411m8,872m8,011m9,600m8,853m
Current liabilities2,821m2,836m3,230m3,333m4,236m4,745m6,503m6,511m
Total capital12,633m11,267m12,691m14,475m26,226m21,065m19,532m17,338m
Total debt3,512m3,477m5,961m6,804m18,310m17,213m14,364m13,449m
Total equity9,124m7,794m7,882m8,689m9,077m5,833m8,402m6,964m
Total non current liabilities--------
Loans3,509m3,473m4,809m5,786m17,149m15,232m11,130m10,374m
Total assets17,111m15,641m18,193m20,019m33,521m28,287m28,276m25,782m
Total liabilities--------
Cash and cash equivalents3,394m1,832m3,335m3,730m2,951m1,718m3,194m1,764m
Common stock541m513m506m505m502m504m508m511m

Cash flow

Year
chevron-l-regular
chevron-r-regular
20172018201920202021202220232024
Cash at beginning of period2,801m3,394m1,838m3,335m3,736m2,956m1,722m3,198m
Cash dividends paid-315m-376m-423m-473m-530m-573m-586m-590m
1,203m1,415m1,408m1,159m1,479m532m1,034m559m
Investments (gains) losses-1,310m-938m-1,100m-1,179m-11,200m-931m3,213m-626m
3,394m1,832m3,335m3,736m2,956m1,722m3,198m2,414m
Net income--------
1,837m2,096m2,104m1,868m2,222m1,211m1,726m1,019m
-634m-681m-696m-709m-743m-679m-692m-460m
The figures shown in the tables are quoted in the currency of the stock selected.
Please note that past performance is not a reliable indicator of future returns. Please use the interactive graph for benchmark comparison.


Important Information

Please note the value of investments can go down as well as up so you may get back less than you invested. This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to an authorised financial adviser. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and(3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.
© Copyright 2025 Morningstar. All rights reserved.